Azurify integrates cancer genomics with machine learning to classify the clinical significance of somatic variants
Bigdeli, A.; Chandrashekar, D. S.; Chitturi, A.; Rushton, C.; Mackinnon, A. C.; Segal, J.; Harada, S.; Sacan, A.; Faryabi, R. B.
Show abstract
Accurate classification of somatic variations from high-throughput sequencing data has become integral to diagnostics and prognostics across various cancers. However, the classification of these variations remains highly manual, inherently variable, and largely inaccessible outside specialized laboratories. Here, we introduce Azurify - a computational tool that integrates machine learning, public resources recommended by professional societies, and clinically annotated data to classify the pathogenicity of variations in precision cancer medicine. Trained on over 15,000 clinically classified variants from 8,202 patients across 138 cancer phenotypes, Azurify achieves 99.1% classification accuracy for concordant pathogenic variants in data from two external clinical laboratories. Additionally, Azurify reliably performs precise molecular profiling in leukemia cases. Azurifys unified, scalable, and modular framework can be easily deployed within bioinformatics pipelines and retrained as new data emerges. In addition to supporting clinical workflows, Azurify offers a high-throughput screening solution for research, enabling genomic studies to identify meaningful variant-disease associations with greater efficiency and consistency.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- MetaRNN: Differentiating Rare Pathogenic and Rare Benign Missense SNVs and InDels Using Deep Learning 95%
- From Text to Translation: Using Language Models to Prioritize Variants for Clinical Review 94%
- OncoGEMINI: Software for Investigating Tumor Variants From Multiple Biopsies With Integrated Cancer Annotations 94%
Similar papers in this journal
- Discovering Monogenic Patients with a Confirmed Molecular Diagnosis in Millions of Clinical Notes with MonoMiner 94%
- Informing Variant Assessment using Structured Evidence from Prior Classifications (PS1, PM5, and PVS1 Sequence Variant Interpretation Criteria) 94%
- The Importance of Automation in Genetic Diagnosis: Lessons from Analyzing an Inherited Retinal Degeneration Cohort with the Mendelian Analysis Toolkit (MATK) 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- A protein-centric approach for exome variant aggregation enables sensitive association analysis with clinical outcomes 94%
- Cancer SIGVAR: A semi-automated interpretation tool for germline variants of hereditary cancer-related genes 92%
- GeneBreaker: Variant simulation to improve the diagnosis of Mendelian rare genetic diseases 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.